Description: 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems. It offers chromium instruments, enzymes, reagents, microfluidic chips, and other consumable products, as well as software for analyzing biological systems. The company serves researchers in approximately 40 countries. Its customers include a range of academic, government, biopharmaceutical, biotechnology, and other institutions worldwide. 10X Genomics, Inc. was formerly known as 10X Technologies, Inc. and changed its name to 10X Genomics, Inc. in November 2014. The company was incorporated in 2012 and is based in Pleasanton, California.
Home Page: www.10xgenomics.com
TXG Technical Analysis
6230 Stoneridge Mall Road
Pleasanton,
CA
94588-3260
United States
Phone:
925 401 7300
Officers
| Name | Title |
|---|---|
| Dr. Serge Saxonov Ph.D. | Co-Founder, CEO & Director |
| Dr. Benjamin J. Hindson Ph.D. | Co-Founder, Pres, Chief Scientific Officer & Director |
| Mr. Justin J. McAnear | Chief Financial Officer |
| Mr. Eric S. Whitaker Esq. | Chief Legal Officer |
| Mr. Michael Schnall-Levin | Founding Scientist & CTO |
| Ms. Cassie Corneau | Mang. of Investor Relations and Strategic Fin. |
| Mr. Jonathan Schimmel | VP of Global Support & Sales Operations |
| Ms. Rebecca Port | Chief People Officer |
| Ms. Ruth De Backer | Chief Bus. Officer |
| Mr. Jim Wilbur Ph.D. | Chief Commercial Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Life Sciences Tools & Services |
| GIC Sub-Industry: |
| Forward PE: | 196.0784 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 5.1581 |
| Price-to-Sales TTM: | 8.1308 |
| IPO Date: | 2019-09-12 |
| Fiscal Year End: | December |
| Full Time Employees: | 1239 |